Shire Prevails In Patent Trial Over Mylan's Generic Lialda
Following a four-day bench trial held in September, a Florida federal judge concluded on Friday that Mylan Pharmaceuticals Inc.'s proposed generic version of Shire Development LLC's bowel disease drug Lialda infringes...To view the full article, register now.
Already a subscriber? Click here to view full article